Why is fake medicine common in Africa?

In the podcast with Deutsche Welle, Claudia Martínez, Head of Research at the Access to Medicine Foundation, discusses the critical public health threat of substandard and counterfeit medicines in Africa. 

The podcast highlights the pressing issue of widespread substandard and counterfeit medicines in low- and middle-income countries, especially in Africa. Weak regulatory systems, insufficient enforcement, and fragmented supply chains create opportunities for fake medicines to penetrate the market. 

The presence of substandard and counterfeit medicines not only undermines patient trust but also poses significant challenges for governments, as these drugs frequently evade regulatory oversight, complicating prevention efforts.

Claudia emphasises the need for multi-level solutions, including frameworks to enhance access to medicines, assess the quality, and raise patient awareness. Some African countries are gradually implementing government initiatives like serialisation and track-and-trace systems, enabling patients to verify and report counterfeit medicines. Additionally, individuals can contribute by purchasing from reputable sources and licensed pharmacies. Ultimately, a shift towards structural changes is essential to empower regulatory authorities to establish and enforce effective regulations.